CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...
Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The content of this article is ...
GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...
GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...
President Trump supports the Japanese company’s taking a stake in the American steel maker after the U.S. blocked a $14 billion takeover bid. By Alan Rappeport Alan Rappeport reports on economic ...
President Trump said he supported Nippon Steel to invest in U.S. Steel instead of purchasing it at a press conference with Japanese Prime Minister Shigeru Ishiba. Photo: Mandel Ngan/AFP/Getty ...
After hours: February 7 at 6:55:00 PM EST Loading Chart for GSK ...
Teva Pharmaceutical Industries Ltd. ADR-2.66% $19.77B ...
2-Year U.S. Treasury Note Continuous Contract $102.707-0.016-0.02% 5-Year U.S. Treasury Note Continuous Contract $106.445-0.016-0.01% 10-Year U.S. Treasury Note Continuous Contract $109.219-0.016 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback